The global gene silencing market size is expected to reach USD 21.29 billion by 2030 and is expected to grow at 13.8% CAGR from 2025 to 2030. The market is experiencing significant growth due to increasing recognition of genetic disorders and urgent need for effective therapies. Over the past few years, advancements in gene silencing technologies, including RNA interference (RNAi), antisense oligonucleotides (ASOs), and CRISPR-based approaches, have led to breakthroughs in treating previously untreatable genetic diseases. As research intensifies, pharmaceutical and biotechnology companies are allocating more resources to developing gene silencing therapies to address the unmet medical needs of patients suffering from genetic conditions such as Huntington’s disease, muscular dystrophy, and rare cancers. This growing demand for innovative, targeted therapies is a key driver for the market.
The COVID-19 pandemic, while disruptive in many areas, also highlighted the importance of gene-based therapies and accelerated the development of gene silencing technologies. During the pandemic, increased funding and collaboration between research institutions and pharmaceutical companies led to the rapid development of vaccine technologies, highlighting the potential of gene silencing strategies for tackling a wide range of diseases. In addition, the pandemic led to a greater focus on genetic research and innovation in drug discovery, driving the need for gene silencing solutions in areas such as viral infections, cancer treatment, and autoimmune disorders. As a result, gene silencing technologies have garnered more attention, positioning them as a critical component in the future of precision medicine.
Furthermore, the growing availability of gene silencing-related services has fueled market expansion. Contract research organizations (CROs) and contract manufacturing organizations (CMOs) have become integral partners for biotech and pharmaceutical companies developing gene silencing therapies. These service providers offer expertise in clinical trials, regulatory compliance, and scalable manufacturing, enabling faster and more cost-effective development of gene silencing-based drugs. The pandemic underscored the need for robust and scalable production systems, driving further demand for services that support gene therapy development. This trend is expected to continue as the pipeline for gene silencing products expands and as companies work to meet the increasing demand for these advanced therapeutic options.
This product will be delivered within 1-3 business days.
The COVID-19 pandemic, while disruptive in many areas, also highlighted the importance of gene-based therapies and accelerated the development of gene silencing technologies. During the pandemic, increased funding and collaboration between research institutions and pharmaceutical companies led to the rapid development of vaccine technologies, highlighting the potential of gene silencing strategies for tackling a wide range of diseases. In addition, the pandemic led to a greater focus on genetic research and innovation in drug discovery, driving the need for gene silencing solutions in areas such as viral infections, cancer treatment, and autoimmune disorders. As a result, gene silencing technologies have garnered more attention, positioning them as a critical component in the future of precision medicine.
Furthermore, the growing availability of gene silencing-related services has fueled market expansion. Contract research organizations (CROs) and contract manufacturing organizations (CMOs) have become integral partners for biotech and pharmaceutical companies developing gene silencing therapies. These service providers offer expertise in clinical trials, regulatory compliance, and scalable manufacturing, enabling faster and more cost-effective development of gene silencing-based drugs. The pandemic underscored the need for robust and scalable production systems, driving further demand for services that support gene therapy development. This trend is expected to continue as the pipeline for gene silencing products expands and as companies work to meet the increasing demand for these advanced therapeutic options.
Gene Silencing Market Report Highlights
- By product & service, services is expected to witness the fastest growth with a CAGR of 14.2% during the forecast period. The complexity of gene silencing techniques has created a need for expert support in clinical trial management, regulatory guidance, and bioinformatics analysis. This rising demand for customized solutions and end-to-end services is fueling market expansion
- By application, the drug discovery & development segment dominated the market and captured the largest revenue share in 2024. Advances in high-throughput screening, bioinformatics tools, and genomic databases have enhanced target identification and validation processes and are expected to fuel global market growth
- By end use, the pharmaceutical & biotechnology companies segment dominated the market and accounted for the largest revenue share in 2024. The market is driven by the increasing focus on precision medicine and the potential of gene-based therapies to treat a wide range of genetic disorders, cancers, and rare diseases
- North America held the largest share of 48.23% in 2024. The presence of a population with high susceptibility to rare diseases, increased market penetration rates, and technologically advanced healthcare infrastructure support the region’s growth
- A few of the key market players include Revvity, Inc., Danaher, Agilent Technologies, GenScript, Merck KGaA, Thermo Fisher Scientific, Inc., Illumina, Bio-Rad Laboratories, Bio-Techne, New England Biolabs, Inc.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This Report Addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product & Service
1.2.2. Application
1.2.3. End Use
1.3. Research Methodology
1.4. Information Procurement
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Gene Silencing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising Prevalence of Genetic Disorders
3.2.1.2. Technological Advancements in Delivery Systems
3.2.2. Market restraint analysis
3.2.2.1. High Development Costs and Complex Manufacturing
3.2.2.2. Regulatory and Ethical Challenges
3.3. Gene Silencing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Gene Silencing Market: Product & Service Estimates & Trend Analysis
4.1. Product & Service Segment Dashboard
4.2. Global Gene Silencing Market Product & Service Movement Analysis
4.3. Global Gene Silencing Market Size & Trend Analysis, by Product & Service, 2018 - 2030 (USD Million)
4.4. Products
4.5. Products Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)
4.5.1. RNAi
4.5.1.1. RNAi Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.1.2. miRNA
4.5.1.2.1. miRNA Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.1.3. siRNA
4.5.1.3.1. siRNA Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.1.4. Others
4.5.1.5. Others Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.2. CRISPR-Cas9
4.5.2.1. CRISPR-Cas9 Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.2.2. CRISPR Kits & Reagents
4.5.2.2.1. CRISPR Kits & Reagents Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.2.3. CRISPR Libraries
4.5.2.3.1. CRISPR Libraries Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.2.4. Others
4.5.2.5. Others Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.3. Antisense Oligonucleotides
4.5.3.1. Antisense Oligonucleotides Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.4. Others
4.5.4.1. Others Market estimates and forecasts 2018 - 2030 (USD Million)
4.6. Services
4.6.1. Services Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)
Chapter 5. Gene Silencing Market: Application Estimates & Trend Analysis
5.1. Application Segment Dashboard
5.2. Global Gene Silencing Market Application Movement Analysis
5.3. Global Gene Silencing Market Size & Trend Analysis, by Application, 2018 - 2030 (USD Million)
5.4. Drug Discovery & Development
5.5. Drug Discovery & Development Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)
5.5.1. Neurology
5.5.1.1. Neurology Market estimates and forecasts 2018 - 2030 (USD Million)
5.5.2. Oncology
5.5.2.1. Oncology Market estimates and forecasts 2018 - 2030 (USD Million)
5.5.3. Infectious Diseases
5.5.3.1. Infectious Diseases Market estimates and forecasts 2018 - 2030 (USD Million)
5.5.4. Metabolic Diseases
5.5.4.1. Metabolic Diseases Market estimates and forecasts 2018 - 2030 (USD Million)
5.5.5. Others
5.5.5.1. Others Market estimates and forecasts 2018 - 2030 (USD Million)
5.6. Therapeutics Manufacturing
5.6.1. Therapeutics Manufacturing Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)
5.7. Agricultural Applications
5.7.1. Agricultural Applications Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)
5.8. Others
5.8.1. Others Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)
Chapter 6. Gene Silencing Market: End Use Estimates & Trend Analysis
6.1. End Use Segment Dashboard
6.2. Global Gene Silencing Market End Use Movement Analysis
6.3. Global Gene Silencing Market Size & Trend Analysis, by End Use, 2018 - 2030 (USD Million)
6.4. Pharmaceutical & Biotechnology Companies
6.4.1. Pharmaceutical & Biotechnology Companies Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)
6.5. Academic & Research Institutes
6.5.1. Academic & Research Institutes Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)
6.6. CROs & CMOs
6.6.1. CROs & CMOs Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)
6.7. Others
6.7.1. Others Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)
Chapter 7. Gene Silencing Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
7.3.3. Mexico
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework
7.3.3.3. Competitive scenario
7.3.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
7.4.6. Norway
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework
7.4.6.3. Competitive scenario
7.4.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework
7.4.8.3. Competitive scenario
7.4.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
7.5.4. Australia
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework
7.5.4.3. Competitive scenario
7.5.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework
7.5.5.3. Competitive scenario
7.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
7.6.2. Argentina
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive scenario
7.6.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Categorization
8.2. Company Market Position Analysis, 2024
8.3. Strategy Mapping
8.4. Participants Overview
8.4.1. Revvity, Inc.
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Danaher
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Agilent Technologies
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. GenScript
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Merck KGaA
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Thermo Fisher Scientific, Inc.
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Illumina
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Bio-Rad Laboratories
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Bio-Techne
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. New England Biolabs, Inc.
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America Gene Silencing Market, by Region, 2018 - 2030 (USD Million)
Table 3 North America Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 4 North America Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 5 North America Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
Table 6 U.S. Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 7 U.S. Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 8 U.S. Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
Table 9 Canada Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 10 Canada Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 11 Canada Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
Table 12 Mexico Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 13 Mexico Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 14 Mexico Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
Table 15 Europe Gene Silencing Market, by Region, 2018 - 2030 (USD Million)
Table 16 Europe Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 17 Europe Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 18 Europe Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
Table 19 UK Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 20 UK Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 21 UK Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
Table 22 Germany Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 23 Germany Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 24 Germany Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
Table 25 Italy Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 26 Italy Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 27 Italy Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
Table 28 France Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 29 France Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 30 France Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
Table 31 Spain Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 32 Spain Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 33 Spain Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
Table 34 Sweden Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 35 Sweden Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 36 Sweden Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
Table 37 Denmark Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 38 Denmark Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 39 Denmark Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
Table 40 Norway Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 41 Norway Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 42 Norway Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
Table 43 Asia Pacific Gene Silencing Market, by Region, 2018 - 2030 (USD Million)
Table 44 Asia Pacific Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 45 Asia Pacific Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
Table 47 China Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 48 China Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 49 China Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
Table 50 Japan Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 51 Japan Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 52 Japan Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
Table 53 India Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 54 India Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 55 India Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
Table 56 South Korea Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 57 South Korea Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 58 South Korea Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
Table 59 Australia Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 60 Australia Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 61 Australia Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
Table 62 Thailand Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 63 Thailand Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 64 Thailand Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
Table 65 Latin America Gene Silencing Market, by Region, 2018 - 2030 (USD Million)
Table 66 Latin America Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 67 Latin America Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 68 Latin America Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
Table 69 Brazil Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 70 Brazil Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 71 Brazil Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
Table 72 Argentina Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 73 Argentina Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 74 Argentina Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
Table 75 Middle East Africa Gene Silencing Market, by Region, 2018 - 2030 (USD Million)
Table 76 Middle East Africa Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 77 Middle East Africa Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 78 Middle East Africa Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
Table 79 South Africa Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 80 South Africa Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 81 South Africa Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
Table 85 UAE Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 86 UAE Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 87 UAE Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
Table 88 Kuwait Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
Table 89 Kuwait Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
Table 90 Kuwait Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market Research Process
Fig. 2 Data Triangulation Techniques
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value-Chain-Based Sizing & Forecasting
Fig. 6 QFD Modeling for Market Share Assessment
Fig. 7 Market formulation & Validation
Fig. 8 Gene Silencing Market: Market Outlook
Fig. 9 Parent Market Outlook
Fig. 10 Related/Ancillary Market Outlook
Fig. 11 Penetration and Growth Prospect Mapping
Fig. 12 Industry Value Chain Analysis
Fig. 13 Gene Silencing Market Driver Impact
Fig. 14 Gene Silencing Market Restraint Impact
Fig. 15 Gene Silencing Market Strategic Initiatives Analysis
Fig. 16 Gene Silencing Market: Product & Service Movement Analysis
Fig. 17 Gene Silencing Market: Product & Service Outlook and Key Takeaways
Fig. 18 Products Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 19 RNAi Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 20 miRNA Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 21 siRNA Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 22 Others Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 23 CRISPR-Cas9 Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 24 CRISPR Kits & Reagents Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 25 CRISPR Libraries Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 26 Others Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 27 Antisense Oligonucleotides Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 28 Others Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 29 Services Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 30 Gene Silencing Market: Application Movement Analysis
Fig. 31 Gene Silencing Market: Application Outlook and Key Takeaways
Fig. 32 Drug Discovery & Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 33 Neurology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 34 Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 35 Infectious Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 36 Metabolic Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 37 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 38 Therapeutics Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 39 Agricultural Applications Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 40 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 41 Gene Silencing Market: End-Use Movement Analysis
Fig. 42 Gene Silencing Market: End-Use Outlook and Key Takeaways
Fig. 43 Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 44 Academic & Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 45 CROs & CMOs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 46 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 47 Global Gene Silencing Market: Regional Movement Analysis
Fig. 48 Global Gene Silencing Market: Regional Outlook and Key Takeaways
Fig. 49 North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 50 U.S. Country Dynamics
Fig. 51 U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 52 Canada Country Dynamics
Fig. 53 Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 54 Mexico Country Dynamics
Fig. 55 Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 56 Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 57 UK Country Dynamics
Fig. 58 UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 59 Germany Country Dynamics
Fig. 60 Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 61 France Country Dynamics
Fig. 62 France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 63 Italy Country Dynamics
Fig. 64 Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 65 Spain Country Dynamics
Fig. 66 Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 67 Denmark Country Dynamics
Fig. 68 Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 69 Sweden Country Dynamics
Fig. 70 Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 71 Norway Country Dynamics
Fig. 72 Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 73 Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 74 China Country Dynamics
Fig. 75 China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 76 Japan Country Dynamics
Fig. 77 Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 78 India Country Dynamics
Fig. 79 India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 80 Thailand Country Dynamics
Fig. 81 Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 82 South Korea Country Dynamics
Fig. 83 South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 84 Australia Country Dynamics
Fig. 85 Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 86 Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 87 Brazil Country Dynamics
Fig. 88 Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 89 Argentina Country Dynamics
Fig. 90 Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 91 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 92 South Africa Country Dynamics
Fig. 93 South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 94 Saudi Arabia Country Dynamics
Fig. 95 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 96 UAE Country Dynamics
Fig. 97 UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 98 Kuwait Country Dynamics
Fig. 99 Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 100 Market Position of Key Market Players
Companies Mentioned
- Revvity, Inc.
- Danaher
- Agilent Technologies
- GenScript
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Illumina
- Bio-Rad Laboratories
- Bio-Techne
- New England Biolabs, Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | March 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 9.92 Billion |
| Forecasted Market Value ( USD | $ 21.29 Billion |
| Compound Annual Growth Rate | 13.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
